ST
Healthcare & Life Sciences
Sangamo Therapeutics
United Statessangamo.com
Sangamo Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Sangamo Therapeutics
Based in the United States, Sangamo Therapeutics is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Sangamo Therapeutics develops genomic medicine therapies using proprietary zinc finger technology to create genetic cures for severe diseases, focusing on neurological, oncological, and rare genetic conditions.
Explore Sangamo Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.